Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Oct. 30, 2020	Nov. 01, 2019
Cash flows from operating activities:
Net loss	$ (12,371)	$ (26,438)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	30,978	32,017
Stock-based compensation expense	17,675	15,617
Effects of exchange rate changes on monetary assets and liabilities denominated in foreign currencies	(1,190)	(102)
Income tax benefit	(5,309)	(12,254)
Other non cash impacts	150	1,830
Provision for doubtful accounts	1,871	1,651
Changes in assets and liabilities, net of effect of business combination:
Accounts receivable	2,296	21,689
Net transactions with parent	5,586	(18,571)
Inventories	56	(438)
Other assets	5,593	10,838
Accounts payable	2,668	9,086
Deferred revenue	(4,820)	9,848
Accrued and other liabilities	(14,749)	(8,921)
Net cash provided by operating activities	28,434	35,852
Cash flows from investing activities:
Capital expenditures	(2,181)	(12,082)
Acquisition of business, net of cash acquired	(15,081)	0
Net cash used in investing activities	(17,262)	(12,082)
Cash flows from financing activities:
Taxes paid on vested restricted shares	(4,962)	(8,197)
Purchases of stock for treasury	0	(6,377)
Net cash used in financing activities	(4,962)	(14,574)
Net increase in cash and cash equivalents	6,210	9,196
Cash and cash equivalents at beginning of the period	181,838	129,592
Cash and cash equivalents at end of the period	$ 188,048	$ 138,788